Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Review of in silico studies dedicated to the nuclear receptor family: Therapeutic prospects and toxicological concerns. | Front Endocrinol (Lausanne) | 2022 | 36176461 | PubTator, text mining | PubMed |
| Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition. | Oncogene | 2022 | 36153371 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer. | Int J Mol Sci | 2022 | 36142451 | PubTator, text mining | PubMed |
| Recent Advances in PROTACs for Drug Targeted Protein Research. | Int J Mol Sci | 2022 | 36142231 | PubTator, text mining | PubMed |
| Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. | Biomedicines | 2022 | 36140200 | PubTator, text mining | PubMed |
| Induction of BVR-A Expression by Korean Red Ginseng in Murine Hippocampal Astrocytes: Role of Bilirubin in Mitochondrial Function via the LKB1-SIRT1-ERRα Axis. | Antioxidants (Basel) | 2022 | 36139815 | PubTator, text mining | PubMed |
| Recent Advances of Degradation Technologies Based on PROTAC Mechanism. | Biomolecules | 2022 | 36139095 | PubTator, text mining | PubMed |
| HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis. | JCI Insight | 2022 | 36134662 | PubTator, text mining | PubMed |
| Thyroid hormone-dependent oligodendroglial cell lineage genomic and non-genomic signaling through integrin receptors. | Front Pharmacol | 2022 | 36133808 | PubTator, text mining | PubMed |
| Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. | PLoS One | 2022 | 36129905 | PubTator, text mining | PubMed |
| Editorial: The bone/bone marrow microenvironment: A hub for immune regulation of the tumor cells fate. | Front Immunol | 2022 | 36119043 | PubTator, text mining | PubMed |
| Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. | Signal Transduct Target Ther | 2022 | 36115852 | PubTator, text mining | PubMed |
| Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets. | Transl Oncol | 2022 | 36113343 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency. | Commun Biol | 2022 | 36097051 | PubTator, text mining | PubMed |
| Biological effects and regulation of IGFBP5 in breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36093095 | PubTator, text mining | PubMed |
| Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes. | J Clin Med | 2022 | 36078876 | PubTator, text mining | PubMed |
| Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling. | Cancers (Basel) | 2022 | 36077653 | PubTator, text mining | PubMed |
| A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors. | Int J Mol Sci | 2022 | 36077415 | PubTator, text mining | PubMed |
| The Regulatory Role of Lipid Metabolism in Endometrial Cancer. | J Oncol | 2022 | 36072980 | PubTator, text mining | PubMed |
| Relationship between metabolic reprogramming and drug resistance in breast cancer. | Front Oncol | 2022 | 36059650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=28